Efficacy and Safety of Frontline Single‐Agent Rituximab in Extranodal Marginal Zone LymphomaCamilla Mazzoni, Pier Luigi Zinzani, Matteo Carella et al.|European Journal Of Haematology|2024Cited by 3
Immune Checkpoint Inhibitors in Primary Mediastinal B-Cell Lymphoma: A Monocentric Real-Life Experience and Future PotentialPier Luigi Zinzani, Alessandro Broccoli, Lisa Argnani et al.|Blood|2024Cited by 0
Pre-treatment circulating microRNA signatures predict outcomes of anti-CD19 CAR T-cell therapyMaria Naddeo, Francesca Bonifazi, Roberta Roncarati et al.|Haematologica|2026Cited by 0
Sarcoid-like Reactions in Hodgkin Lymphoma Treated with Pembrolizumab: a Case ReportPier Luigi Zinzani, Lisa Argnani, Flavia Salvatore et al.|Mediterranean Journal of Hematology and Infectious Diseases|2026Cited by 0